Su X - Search Results

1

Target Inhibition of CBP Induced Cell Senescence in BCR-ABL- T315I Mutant Chronic Myeloid Leukemia.

Yang K, Wang F, Zhang H, Wang X, Chen L, Su X, Wu X, Han Q, Chen Z, Chen ZS, Fu L. Yang K, et al. Among authors: su x. Front Oncol. 2021 Jan 8;10:588641. doi: 10.3389/fonc.2020.588641. eCollection 2020. Front Oncol. 2021. PMID: 33585207 Free PMC article.

2

[Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].

Wei WD, Wen ZS, Su XD, Lin P, Rong TH, Chen LK. Wei WD, et al. Ai Zheng. 2007 Nov;26(11):1231-6. Ai Zheng. 2007. PMID: 17991324 Free article. Chinese.

3

Emodin azide methyl anthraquinone derivative triggers mitochondrial-dependent cell apoptosis involving in caspase-8-mediated Bid cleavage.

Yan Y, Su X, Liang Y, Zhang J, Shi C, Lu Y, Gu L, Fu L. Yan Y, et al. Among authors: su x. Mol Cancer Ther. 2008 Jun;7(6):1688-97. doi: 10.1158/1535-7163.MCT-07-2362. Mol Cancer Ther. 2008. PMID: 18566240

4

Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.

Dai CL, Tiwari AK, Wu CP, Su XD, Wang SR, Liu DG, Ashby CR Jr, Huang Y, Robey RW, Liang YJ, Chen LM, Shi CJ, Ambudkar SV, Chen ZS, Fu LW. Dai CL, et al. Cancer Res. 2008 Oct 1;68(19):7905-14. doi: 10.1158/0008-5472.CAN-08-0499. Cancer Res. 2008. PMID: 18829547 Free PMC article.

5

Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function.

Dai CL, Liang YJ, Chen LM, Zhang X, Deng WJ, Su XD, Shi Z, Wu CP, Ashby CR Jr, Akiyama S, Ambudkar SV, Chen ZS, Fu LW. Dai CL, et al. Among authors: su xd. Biochem Pharmacol. 2009 Aug 15;78(4):355-64. doi: 10.1016/j.bcp.2009.04.023. Epub 2009 May 3. Biochem Pharmacol. 2009. PMID: 19410561 Free PMC article.

6

Reversal of P-gp-mediated multidrug resistance by Bromotetrandrine in vivo is associated with enhanced accumulation of chemotherapeutical drug in tumor tissue.

Chen LM, Liang YJ, Zhang X, Su XD, Dai CL, Wang FP, Yan YY, Tao LY, Fu LW. Chen LM, et al. Among authors: su xd. Anticancer Res. 2009 Nov;29(11):4597-604. Anticancer Res. 2009. PMID: 20032409 Free article.

7

Effect of BIBF 1120 on reversal of ABCB1-mediated multidrug resistance.

Xiang QF, Wang F, Su XD, Liang YJ, Zheng LS, Mi YJ, Chen WQ, Fu LW. Xiang QF, et al. Cell Oncol (Dordr). 2011 Feb;34(1):33-44. doi: 10.1007/s13402-010-0003-7. Epub 2011 Jan 28. Cell Oncol (Dordr). 2011. PMID: 21290212

8

ABCG2-overexpressing S1-M1-80 cell xenografts in nude mice keep original biochemistry and cell biological properties.

Wang F, Liang YJ, Wu XP, Su XD, Fu LW. Wang F, et al. Chin J Cancer. 2012 Mar;31(3):150-8. doi: 10.5732/cjc.011.10310. Epub 2012 Feb 24. Chin J Cancer. 2012. PMID: 22360854 Free PMC article.

9

Saracatinib (AZD0530) is a potent modulator of ABCB1-mediated multidrug resistance in vitro and in vivo.

Liu KJ, He JH, Su XD, Sim HM, Xie JD, Chen XG, Wang F, Liang YJ, Singh S, Sodani K, Talele TT, Ambudkar SV, Chen ZS, Wu HY, Fu LW. Liu KJ, et al. Int J Cancer. 2013 Jan 1;132(1):224-35. doi: 10.1002/ijc.27649. Epub 2012 Jun 13. Int J Cancer. 2013. PMID: 22623106 Free PMC article.

10

Mutation abundance affects the efficacy of EGFR tyrosine kinase inhibitor readministration in non-small-cell lung cancer with acquired resistance.

Zhao ZR, Wang JF, Lin YB, Wang F, Fu S, Zhang SL, Su XD, Jiang L, Zhang YG, Shao JY, Long H. Zhao ZR, et al. Med Oncol. 2014 Jan;31(1):810. doi: 10.1007/s12032-013-0810-6. Epub 2013 Dec 14. Med Oncol. 2014. PMID: 24338271

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,434 results

Search Page

Filters